Skip to content

MIMETAS vs StemoniX

MIMETAS logo

MIMETAS

Human Tissue Models for Better Therapies

93 employees · est. 2013 · The Netherlands

VS
StemoniX logo

StemoniX

Pre-plated, human iPSC-derived microOrgans for toxicology and drug discovery research

1 employees · est. 2014 · Maple Grove, United States

MIMETAS is the older company (2013 vs 2014); MIMETAS is the larger of the two.

Side-by-Side Comparison

MIMETAS StemoniX
Founded
2013 older 2014
Headquarters
The Netherlands Maple Grove, United States
Employees
93 larger 1
Industry
Biotechnology, Health Care, Information Technology Biotechnology, Health Care
Funding Stage
Grant Convertible Note
Total Funding
$31.91M $33.21M
Funding Rounds
5 11
Services
CRO Services, Training, Product Development, AI/Automation, Disease Mechanism Understanding, Drug Efficacy and Safety Testing, Target Discovery and Validation, Compound Prioritization and Derisking Not tracked yet
Target Customers
Pharmaceutical Companies, Biotech Companies, Academic Researchers, Healthcare Researchers, Regulatory Agencies Not tracked yet
Taxonomy
Organ-on-a-Chip3D Human Disease ModelsPredictive ToxicologyMicrofluidicsCell-based AssaysHigh-throughput Screening +9 Stem Cell TechnologiesDrug DiscoveryPersonalized MedicineIPS CellsCardiomyocytesNeurons +8
Website
mimetas.com stemonix.com
MIMETAS logo

About MIMETAS

MIMETAS, founded in 2013 and headquartered in The Netherlands, operates at the intersection of Biotechnology, Health Care, Information Technology, and VR/AR. The company is renowned for its slogan: Human Tissue Models for Better Therapies. MIMETAS specializes in developing cutting-edge, screenable 3...

StemoniX logo

About StemoniX

StemoniX is a biotechnology startup based in the United States, founded in 2014, focusing on accelerating the discovery of new medicines through the development and scalable manufacture of human induced pluripotent stem (iPS) cell-derived cardiac and neural platforms for drug discovery and developme...

Also comparing in this category

Comparing more than these two?

Get MIMETAS, StemoniX and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does MIMETAS compare?

A PDF of MIMETAS and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

MIMETAS was founded in 2013, based in The Netherlands, with 93 employees. MIMETAS, founded in 2013 and headquartered in The Netherlands, operates at the intersection of Biotechnology, Health Care, Information Technology, and VR/AR. The company is renowned for its slogan: Hu. StemoniX was founded in 2014, based in Maple Grove, United States, with 1 employees. StemoniX is a biotechnology startup based in the United States, founded in 2014, focusing on accelerating the discovery of new medicines through the development and scalable manufacture of human induc.
MIMETAS has raised $31.91M and StemoniX $33.21M. Latest stage: MIMETAS Grant, StemoniX Convertible Note.
Both work in Biotechnology and Health Care and list cell-based assays and disease modeling among their focus areas.

Compare MIMETAS with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at MIMETAS on 8 Jun 2026, and StemoniX on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout